fda glp-1 compounding enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA is moving to restrict
Description
Smart carb options
Learn the symptoms, causes, and how to restore healthy levels with food sources and supplements.
Experts weigh in on the rising trend of microdosing Ozempic and Wegovy.
Not Applied to the Mouth or LipsThis product is not used on the mouth, does not close the lips, and is not intended for breathing modification.
New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.
GLP-1 agonists reduced lung fibrosis in mice after COVID-19 infection
